A more recent insulinoma cell line from a WD tumor, NT-3, has shown promise as an accurate representation of mature beta cells, and has already drawn extensive preclinical research with SSTR2 treatments [55,68,72]. The gene discussed is SSTR2; the disease is pancreatic insulinoma.